Rheumatoid Arthritis News

In addition to the increased risk of rheumatoid arthritis from active smoking found in previous research, a new study finds that even exposure to secondhand smoke is associated with a higher risk of the disease.

The drug, marketed under the brand name Rinvoq, also helped twice as many patients enter remission from their rheumatoid arthritis, according to a report in the Oct. 15 issue of the New England Journal of Medicine.

Starting drug treatment early in rheumatoid arthritis patients may reduce their risk of heart disease, a new study suggests.

People who took methotrexate had small-to-moderate increases in risks for skin cancer, infections, and gastrointestinal, lung and blood problems, according to the study published Feb. 17 in the Annals of Internal Medicine.

The study included 821 RA patients and 2,455 people without the disease. Researchers identified 11 health conditions associated with rheumatoid arthritis, including epilepsy and pulmonary fibrosis.

Rheumatoid arthritis symptoms can include joint pain or swelling, but 40% of patients have symptoms that don't involve the joints, such as fatigue, fever and loss of appetite.

Childhood exposure to secondhand smoke might raise women’s risk of developing rheumatoid arthritis, new research finds.

The investigators found that the disease advanced more quickly among those who were very obese. This was true regardless of the level of inflammation in their joints.

The children born to women with the disease were almost three more likely to develop rheumatoid arthritis themselves, the study found.

These are among the foods that could ease the pain, swelling and stiffness in your joints and even slow progression of the disease, researchers say.

People with rheumatoid arthritis appear to have a higher risk of the lung condition chronic obstructive pulmonary disease (COPD), researchers report.

Study suggests most fish may play role in controlling symptoms

Inflammation from excess weight could lead doctors to think disease is worse in women than it is, study finds

Study may offer new insight into the cause of the joint disorder

Researcher stressed that most children born to women with the autoimmune condition not at risk for seizures

Treating inflammation linked to the joint disease might help lower the risk, researcher says

The FDA cleared the way for what is hoped may be a more affordable version of the popular arthritis drug Enbrel. Tuesday the agency approved Erelzi (etanercept-szzs), a "biosimilar" to Enbrel.

Erelzi is a biosimilar for Enbrel

Biologics are made from living cells and more complicated to replicate, researchers said

Treatment worked some for patients who weren't responding to drugs

But risk declines after quitting, researchers find

Heart, respiratory problems were main contributors to early death, researchers found

Only association was seen, and older women shouldn't take the pill to treat symptoms, experts say

Scientists say they have accidentally found a possible treatment for eczema and rheumatoid arthritis.

Case study showed tofacitinib cleared up skin pigmentation loss in woman after just 2 months